Figure S1: Effect of degree of baseline immunosuppression to plasma level of inflammatory and immune activation markers among virally suppressed HIV patients. Data depicts comparison of plasma levels of inflammatory or immune activation markers in patient with <200cells/cm3 vs >200cells/cm3 at baseline. A) Monocyte activation marker-sCD14, B) Interleukin-10 C) Interleukin-6. For comparison purposes IL-10 and IL-6 values below detection limit were regarded as zero (0). All P values was obtained by Mann–Whitney U test.
(1)Figure S1: Effect of degree of baseline immunosuppression to plasma level of inflammatory and immune activation markers among virally suppressed HIV patients
1
0
0
Volltext
ÄHNLICHE DOKUMENTE
Using data from the COHERE collaboration, we investigated whether primary prophylaxis for pneumocystis pneumonia (PcP) might be withheld in all patients on antiretroviral therapy
Second, to describe our experience of HIV infection among patients who have received a diagnosis of TTP, we analyzed data from the Oklahoma TTP-HUS (hemolytic uremic syndrome)
ΔDAS28-ESR, delta DAS28-ESR, indicating the magnitude of changes from baseline to week 4 in DAS28-ESR; DAS28-ESR, Disease Activity Score in 28 joints using
(C) Kaplan-Meier survival analysis showed that mRNA overexpression of LANCL2 or EGFR was not associated with OS and PFS of IDH1/2-wild-type GBM patients (n=145).... Figure S3 ： The
We investigated this group of patients in order to determine any relationship between degree of immunosuppression during treatment initiation and the subsequent levels of
[r]
Additional file 5: Supplementary Figure S3.. Levels of C1q and C4 in plasma of
Figure S3: Emissions of NMVOC (Tg yr −1 ) from megacities considered in this study.. The legend is read from bottom left to top left, then bottom right to
